Bioelectronics Corp (BIEL)

[GetSeriousOK]

CoPilot did not provide that answer.

Major hurdle: basically every state in the Union requires sellers of FDA-cleared medical devices to be licensed or registered or both.

Furthermore, the company would have to kill ALL current distribution deals because otherwise customers would discover they can buy the ActiPatch much cheaper elsewhere and refuse to buy from these new "Direct Sellers."

Furthermore, these new "Direct Sellers" would be untrained and ignorant about the device (don't pretend they will go through an obligatory "online sales course") and would most likely not provide sales support or customer service after the sale.

Furthermore, the idea that customers would accept paying $100 per device is ludicrous. This plan would alienate ALL current and former users of the device, and the pseudo-intellectual idea that you can raise the price of anything to fool consumers into believing it's more valuable is a fallacy -- it might work in the Art World or for a few select unknown products in niche markets, but this is the Pain market and the ActiPatch has too much easily-found history of selling cheaper.

And once the company goes down this road, there's no going back, is there? That's a HUGE gamble.

No, CoPilot didn't produce that "business analysis." That was FauxPilot, aka SS aka TripTripTripAce.

"Minimal success" will drive the PPS to 25 cents? LOL does FauxPilot really believe that? No. Really?

They allowed you to spew this nonsense on FB for awhile but you lost your audience, and FauxPilot is going to have the same fate here. So why bother?